SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-232408
Filing Date
2018-07-31
Accepted
2018-07-31 08:13:35
Documents
3
Period of Report
2018-07-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d570352d8k.htm 8-K 22097
2 EX-99.1 d570352dex991.htm EX-99.1 12165
3 GRAPHIC g570352g0727171327726.jpg GRAPHIC 4231
  Complete submission text file 0001193125-18-232408.txt   41691
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 18979499
SIC: 2834 Pharmaceutical Preparations